Snapsheet Joins NVIDIA Inception to Accelerate the Development of AI Models that Automate Claims Management Processes for Insurers September 8, 2021
Affinia Therapeutics Announces Indications for Lead Gene Therapy Programs to Advance the Treatment of Neurologic and Neuro-oncologic Diseases supported by Multi-Year Manufacturing Agreement with Lonza Group September 8, 2021
SoulBeing Joins Buoy Health’s Marketplace to Offer Alternative Medicine Services to Consumers September 7, 2021
Insilico Medicine and University of Cambridge Announce a Collaboration on Target Identification for Human Diseases Linked to Protein Liquid-liquid Phase Separation September 7, 2021
Innovent Announces First Patient with Type 2 Diabetes Dosed in a Phase 2 Clinical Trial of IBI362 (a GLP-1R and Glucagon Receptor Dual Agonist) in China September 7, 2021
Adaptimmune Updates Data from its Phase 1 Trial for Liver Cancer at ILCA Showing Clinical Benefit September 5, 2021
Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment September 2, 2021
Insilico Medicine Collaborates with Gray Matter to Fight Age-related Cognitive Decline September 1, 2021